The trial began at Kaiser Permanente Washington Health Research Institute in Seattle and will enroll 45 healthy volunteers who are 18 to 55 years old. Patients will be enrolled on a rolling basis, and the first phase of the trial will run about six weeks. This is the first of multiple steps in the clinical trial to evaluate the potential benefit of the vaccine. Specialists say that it will be at least a year before any of the multiple vaccines in development by drug makers around the world could be deployed.
anonymousCoronavirus March 17, 2020 at 4:04 pm
00
Thought Tags
Get Social and Share